Carbamoyl Phosphate Synthetase 1 Deficiency
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Carbamoyl Phosphate Synthetase 1 Deficiency

View Main Condition: Urea Cycle Disorders (UCD)

What is the definition of Carbamoyl Phosphate Synthetase 1 Deficiency?

Carbamoyl phosphate synthetase I deficiency is an inherited disorder that causes ammonia to accumulate in the blood (hyperammonemia). Ammonia, which is formed when proteins are broken down in the body, is toxic if the levels become too high. The brain is especially sensitive to the effects of excess ammonia.

What are the causes of Carbamoyl Phosphate Synthetase 1 Deficiency?

Mutations in the CPS1 gene cause carbamoyl phosphate synthetase I deficiency. The CPS1 gene provides instructions for making the enzyme carbamoyl phosphate synthetase I. This enzyme participates in the urea cycle, which is a sequence of biochemical reactions that occurs in liver cells. The urea cycle processes excess nitrogen, generated when protein is broken down by the body, to make a compound called urea that is excreted by the kidneys. The specific role of the carbamoyl phosphate synthetase I enzyme is to control the first step of the urea cycle, a reaction in which excess nitrogen compounds are incorporated into the cycle to be processed.

How prevalent is Carbamoyl Phosphate Synthetase 1 Deficiency?

Carbamoyl phosphate synthetase I deficiency is a rare disorder; its overall incidence is unknown. Researchers in Japan have estimated that it occurs in 1 in 800,000 newborns in that country.

Is Carbamoyl Phosphate Synthetase 1 Deficiency an inherited disorder?

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Who are the top Carbamoyl Phosphate Synthetase 1 Deficiency Local Doctors?
Elite in Carbamoyl Phosphate Synthetase 1 Deficiency
Elite in Carbamoyl Phosphate Synthetase 1 Deficiency
Referral may be required
Kumamoto, JP 

Jun Kido practices practicing medicine in Kumamoto, Japan. Mr. Kido is rated as an Elite expert by MediFind in the treatment of Carbamoyl Phosphate Synthetase 1 Deficiency. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Urea Cycle Disorders (UCD), Citrullinemia, Carbamoyl Phosphate Synthetase 1 Deficiency, Argininosuccinic Aciduria, and Liver Transplant.

Advanced in Carbamoyl Phosphate Synthetase 1 Deficiency
Geriatrics | Internal Medicine
Advanced in Carbamoyl Phosphate Synthetase 1 Deficiency
Geriatrics | Internal Medicine
Referral may be required

Suburban Geriatrics Inc

2901 Jolly Road, 
Plymouth Meeting, PA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Robert Pearlstein is a primary care provider, practicing in Geriatrics and Internal Medicine in Plymouth Meeting, Pennsylvania. Dr. Pearlstein is rated as an Advanced provider by MediFind in the treatment of Carbamoyl Phosphate Synthetase 1 Deficiency. He is also highly rated in 180 other conditions, according to our data. His clinical expertise encompasses Dementia, Alzheimer's Disease, Painful Swallowing, Gastrostomy, and Endoscopy. Dr. Pearlstein is board certified in  . Dr. Pearlstein is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Carbamoyl Phosphate Synthetase 1 Deficiency
Family Medicine
Experienced in Carbamoyl Phosphate Synthetase 1 Deficiency
Family Medicine

Johnson City Internal Medicine

301 Med Tech Pkwy, Ste 240, 
Johnson City, TN 
Languages Spoken:
English
Accepting New Patients

Jeremy Elliott is a primary care provider, practicing in Family Medicine in Johnson City, Tennessee. Dr. Elliott is rated as an Experienced provider by MediFind in the treatment of Carbamoyl Phosphate Synthetase 1 Deficiency. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Glucocorticoid-Remediable Aldosteronism, Hypertension, and Familial Hypertension. Dr. Elliott is board certified in American Osteopathic Board Of Family Physicians. Dr. Elliott is currently accepting new patients.

What are the latest Carbamoyl Phosphate Synthetase 1 Deficiency Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: February 01, 2013
Published By: National Institutes of Health